Canaquest Medical Corp (OP: CANQF )

0.0438 -0.0061 (-12.22%)

Streaming Delayed Price Updated: 10:11 AM EDT, Aug 21, 2024 Add to My Watchlist

Price and Volume

Volume	16,150
Open	0.0300
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0499
Today's Range	0.0300 - 0.0438
52wk Range	0.0212 - 0.4399
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

New Leaders Of NY Cannabis Reg Body And Recent Industry Appointments You Need To Know About

June 12, 2024

Chris Alexander, the former head of the New York Office of Cannabis Management (OCM), resigned in May. Gov. Kathy Hochul first announced that Alexander's contract would not be renewed following its end...

Via Benzinga

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

October 31, 2023

Via ACCESSWIRE

Performance

YTD	-86.73%	-86.73%
1 Month	-50.79%	-50.79%
3 Month	-51.28%	-51.28%
6 Month	-75.61%	-75.61%
1 Year	-70.80%	-70.80%

More News

CANAQUEST Announces Award of European Cannabinoid Patent

September 19, 2023

Via ACCESSWIRE

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

July 26, 2023

Via ACCESSWIRE

CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)

April 25, 2023

Via ACCESSWIRE

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

December 08, 2022

Via ACCESSWIRE

CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD

December 12, 2022

Via iCrowdNewswire

CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study

December 09, 2022

Via Benzinga

Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

September 08, 2022

Via ACCESSWIRE

The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More

April 30, 2021

Via Benzinga

CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

April 29, 2021

From CanaQuest Medical Corp.

Via AccessWire

Cannabis Movers & Shakers: CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis

April 13, 2021

Via Benzinga

CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

April 07, 2021

From CanaQuest Medical Corp.

Via AccessWire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.